gms | German Medical Science

65th Annual Meeting of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), Meeting of the Central European Network (CEN: German Region, Austro-Swiss Region and Polish Region) of the International Biometric Society (IBS)

06.09. - 09.09.2020, Berlin (online conference)

A multi-step strategy for rapid development of a research infrastructure for urgent research projects and subsequent pooling of data. Early lessons learned from SARS-CoV-2-pandemic activities

Meeting Abstract

  • Jonas Bienzeisler - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Ariadna Pérez Garriga - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Jonas Fortmann - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Jan Wienströer - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Julia Bley - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Benedikt Bender - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Irina Lutz - Universityhospital RWTH Aachen, IT-Department, Aachen, Germany
  • Lukas Szimtenings - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Benno Dill - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Mark Hellmonds - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Silke Haferkamp - University hospital RWTH Aachen, IT-Department, Aachen, Germany
  • Dirk Müller-Wieland - Medical Faculty RWTH Aachen University, Cardiology, Aachen, Germany
  • Christian Cornelissen - Medical Faculty RWTH Aachen University / Pneumology and internal intensive care medicine, Aachen, Germany
  • Rainer Röhrig - Medical Faculty RWTH Aachen University, Institute for Medical Informatics, Aachen, Germany
  • Raphael W. Majeed - Medical Faculty, RWTH Aachen University, Aachen, Germany
  • Covid-Aachen-STC - Medical Faculty RWTH Aachen University, Aachen, Germany

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie. 65th Annual Meeting of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), Meeting of the Central European Network (CEN: German Region, Austro-Swiss Region and Polish Region) of the International Biometric Society (IBS). Berlin, 06.-09.09.2020. Düsseldorf: German Medical Science GMS Publishing House; 2021. DocAbstr. 457

doi: 10.3205/20gmds206, urn:nbn:de:0183-20gmds2068

Published: February 26, 2021

© 2021 Bienzeisler et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Introduction: Typically, structured observational data of particular diseases for epidemiological and clinical research are collected in clinical registries. From our experience, the technical implementation and the design of such registers are a lengthy process that can easily take months. However, during the SARS-CoV-2-pandemic it was required to be immediately able to collect data in two newly established research databases and later link it to data from the RWTH Aachen Biobank and the data integration centers established during the SMITH Project [1], [2]. Potentially, the data should be connected to non-local research projects e.g. the German medical informatics initiative (MII).

Based on a two-step approach we thus drafted a primitive, yet fully functional manual setup mimicking out-of-the-box solutions, that can potentially be advanced into a state-of-the-art clinical registry.

State of the Art: The substructure for many registries in Germany are the generic concepts of the telematics platform for medical research networks (TMF) [3]. The TMF and the MII are creating a framework for the sustainable use of healthcare data and advise the use of FHIR and I2B2 for clinical research databases.

Concept: We conceptualized an intermediate layer for pooling local data sources and potentially connecting them to non-local sources. We first identified processes that could be handled manually and with out-of-the-box solutions for fast set-up. The dataflow, pseudonymization in cooperation with a trusted third party, and consent management will be an implementation of the generic TMF concepts [3]. These can be implemented as proprietary files, that can be distributed ad-hoc but also allow for the later use of the (automated) open-source solutions developed in the mosaic project [4]. The only technical prerequisite for data-linkage and data capture is a patient log consisting of full name and birthday as well as a completed patient consent.

Data will be later collected in a data warehouse employing the OMOP common data model. The data are processed in an ETL pipeline, that can be first implemented as a script and subsequently integrated into an ETL layer. Perspectively, the collected data can be copied into the data integration centers by providing a FHIR facade for the OMOP CDM [5].

Implementation: After conceptualizing our approach, we start first data capture for linkage after ten days of preparation and intend to implement the DWH for data integration within a few weeks. Study protocols and consent forms can now be finalized accordingly. Studies Using this dataset are published, for example [6], [7].

Lessons learned: We drafted a research infrastructure, the COvid19RegisterINtegrationAachen (CORINA), as an intermediate layer for the sustainable capture of data. In a crisis, immediate roll-out has priority to capture data electronically at all. A manually working framework is required, as it determines the study protocol and the design of the informed consent, blocking data capture. Technical deficits cannot be avoided. The technical architecture has to be chosen in a manner, that doesn't block later development; additional resources have to be budgeted for revisal. Thus, the design of technical and organizational measures is a balance of maintaining structural prerequisites for later development and rapid set-up in small steps.

[*] Covid-Aachen-STC: Marx N, Dreher M, Marx G, Müller-Wieland D, Dahl E, Kuhl C, Röhrig R, Stingl J, Uhlig S

The authors declare that they have no competing interests.

The authors declare that a positive ethics committee vote has been obtained.


References

1.
World Health Organization. Pandemic influenza severity assessment (PISA): a WHO guide to assess the severity of influenza in seasonal epidemics and pandemics. 2017.
2.
Winter A, Stäubert S, Ammon D, et al. Smart medical information technology for healthcare (SMITH). Methods of information in medicine. 2018;57:e92–e105.
3.
Pommerening K. Leitfaden zum Datenschutz in medizinischen Forschungsprojekten: Generische Lösungen der TMF 2.0. Berlin: Med. Wiss. Verl.-Ges.; 2014.
4.
Bialke M, Bahls T, Havemann C, Piegsa J, Weitmann K, Wegner T, Hoffmann W. MOSAIC--A Modular Approach to Data Management in Epidemiological Studies. Methods Inf Med. 2015;54(4):364-371. DOI: 10.3414/ME14-01-0133 External link
5.
Khalilia M, Choi M, Henderson A, Iyengar S, Braunstein M, Sun J. Clinical Predictive Modeling Development and Deployment through FHIR Web Services. AMIA Annu Symp Proc. 2015 Nov 5;2015:717-26.
6.
Koschmieder S, Jost E, Cornelissen C, Müller T, Schulze-Hagen M, Bickenbach J, Marx G, Kleines M, Marx N, Brümmendorf TH, Dreher M. Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis. Eur J Haematol. 2020 Nov;105(5):655-658. DOI: 10.1111/ejh.13480 External link
7.
Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, Daher A, Stöhr R, Kleines M, Lemmen SW, Brokmann JC, Müller T, Müller-Wieland D, Marx G, Marx N. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl Int. 2020 Apr 17;117(16):271-278. DOI: 10.3238/arztebl.2020.0271 External link